Surgery Doctors in Fresno, CA Accepting Medicare

106 Surgery doctors found. Showing 101 - 106

Emily Margaret Kreger, M.D. Surgery - Surgical Critical Care Medicare: Accepting Medicare Assignments Practice Location: 155 N Fresno St, Fresno, CA 93701 Phone: 559-459-5196

Marie Chantal Tran-mccaslin, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 7300 N Fresno St, Fresno, CA 93720 Phone: 858-232-1506

Dr. Ryan Carl Stehr, MD Surgery - Surgery of the Hand Medicare: Accepting Medicare Assignments Practice Location: 2139 E Beechwood Ave, Fresno, CA 93720 Phone: 559-322-6600    Fax: 559-322-4625

David Ray Jeffcoach, Surgery Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-459-3770

Dr. Jose Esteban Alfaro Quezada, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 205 E River Park Cir Ste 460, Fresno, CA 93720 Phone: 559-261-4503

John Chih-chieh Lin, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7575 N Cedar Ave Ste 101, Fresno, CA 93720 Phone: 310-936-4126

News Archive

Marina Biotech, Mirna modify license agreement regarding development of microRNA-based therapeutics

Marina Biotech, Inc., a leading oligonucleotide-based drug discovery and development company, and Mirna Therapeutics, Inc., a privately-held biotechnology company pioneering microRNA replacement therapy for cancer, announced today that they have amended their license agreement regarding the development and commercialization of microRNA-based therapeutics utilizing Mirna's proprietary microRNAs and Marina Biotech's novel SMARTICLES liposomal delivery technology.

Digital versions of standard molecular biology tool to detect common tumor-associated mutation in CSF

Massachusetts General Hospital (MGH) researchers and their colleagues have used digital versions of a standard molecular biology tool to detect a common tumor-associated mutation in the cerebrospinal fluid (CSF) of patients with brain tumors. In their report being published in the open-access journal Molecular Therapy - Nucleic Acids, the investigators describe using advanced forms of the gene-amplification technology polymerase chain reaction (PCR) to analyze bits of RNA carried in membrane-covered sacs called extracellular vesicles for the presence of a tumor-associated mutation in a gene called IDH1.

Scientific data confirms therapeutic potential of Anavex's S1R agonist against Parkinson's disease

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, other diseases of the central nervous system (CNS) and various types of cancer, today announced the findings of a research study published in the current issue of peer-reviewed scientific journal Brain.

Medicare seeks to cut hospital readmissions with 'Care Transitions' project

The Associated Press reports that a "major push is underway around the country to cut rehospitalizations, in part by arming patients with simple steps to keep their recovery on track," such as getting quicker follow-up doctor visits and lessening medication confusion.

CBO offers savings estimate on GOP plan to repeal health law provision

According to the Congressional Budget Office, a bill approved by the House Energy and Commerce Committee that would abolish the law's planning grants designed to help states establish health insurance exchanges could save about $14 billion over the next 10 years. Meanwhile, discussion and debate continues regarding pending legal challenges to the measure.

Read more Medical News

› Verified 8 days ago

• 1
• 2
• 3
• 4
• 5
• 6(current)